Corcept Therapeutics (CORT) Cash from Operations (2010 - 2026)

Corcept Therapeutics (CORT) has 17 years of Cash from Operations data on file, last reported at 16772000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 451.61% year-over-year to 16772000.0; the trailing twelve-month figure through Mar 2026 stood at 120454000.0 (down 32.82% YoY), and the FY2025 full-year result was 141996000.0, down 28.39% from the prior year.
• Cash from Operations retreated to 16772000.0 in Q1 2026, from 38448000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 73293000.0 in Q3 2024 to a low of 16772000.0 in Q1 2026.
• A 5-year average of 33560176.47 and a median of 35247000.0 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations soared 986.24% in 2024 and slumped 451.61% in 2026, its largest moves.
• Tracing CORT's Cash from Operations over 5 years: stood at 33388000.0 in 2022, then tumbled by 83.44% to 5529000.0 in 2023, then soared by 986.24% to 60058000.0 in 2024, then sank by 35.98% to 38448000.0 in 2025, then plunged by 143.62% to 16772000.0 in 2026.
• Business Quant data shows CORT's Cash from Operations at 16772000.0 in Q1 2026, 38448000.0 in Q4 2025, and 54481000.0 in Q3 2025.